SMARCA4 and neuroendocrine carcinoma: As a clear driver for the NEC-like SMARCA4/ARID1A molecular tumor class was not apparent in the available retrospective data, we performed whole exome (n = 9) or NGS panel sequencing (n = 10) of 19 tumors from this group.